Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates

Author(s):  Allen Loyd V Jr

Issue:  May/Jun 2020 - Volume 24, Number 3
View All Articles in Issue

Abstract:  Intravenous admixture compounding requires knowledge of stability, compatibility, and incompatibility issues related to the complete composition and formulation. In evaluating an intravenous admixture, one is not just concerned with the active ingredients but also with all the excipients. Both active pharmaceutical ingredients and excipients used in the formulations of commercially available products may vary among manufacturers and can influence drug compatibility and stability. Clinical pharmaceutics includes the study and application of pharmaceutics to clinical compounding situations to aid in the evaluation of each intravenous admixture. A critical aspect of successful intravenous admixture preparation is the prevention or minimization of particulate matter in the finished product. This article discusses the source, method of prevention, and detection of particulates in intravenous admixtures.

Related Keywords: Loyd V. Allen, Jr, PhD, RPh, parenteral preparations, drug admixtures, intravenous administration, compounded sterile preparations, particulate sources, adverse reactions, visual inspection, compounding standards, United States Pharmacopeia, USP, filtration

Related Categories: PARENTERALS, STABILITIES, COMPATIBILITIES, STERILE PREPARATIONS, QUALITY CONTROL

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Allen Loyd V Jr May/Jun 2020 215-220 Buy
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Allen Loyd V Jr Mar/Apr 2020 92 Buy
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Ashe Krystina, Baskett Dustin Sep/Oct 2018 387-398 Buy
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2 Allen Loyd V Jr May/Jun 2020 180 Buy
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D May/Jun 2004 181-185 Buy
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Martin Matt Sep/Oct 2018 401-404 Buy
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2007 404-410 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2008 440-443 Buy
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Allen Loyd V Jr Jan/Feb 2020 44-50 Buy
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Okeke Claudia C Jul/Aug 2007 302-305 Buy